Zoetis Announces U.S. Label Update for Librela® (bedinvetmab injection), a Treatment to Control Canine Osteoarthritis (OA) PainBusiness Wire • 02/04/25
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2024 Financial ResultsBusiness Wire • 01/07/25
5 Magnificent Dividend Growth Stocks Down 24% to 41% to Buy Before 2025 for a Lifetime of Passive IncomeThe Motley Fool • 12/19/24
4 Stocks in Focus That Declared Dividend Hikes Amid Market VolatilityZacks Investment Research • 12/16/24
A Once-in-a-Decade Opportunity: 2 Magnificent S&P 500 Stocks Down 37% and 28% to Buy Before 2025The Motley Fool • 12/13/24
Zoetis Declares First Quarter 2025 Dividend; Board Approves 16% Payment IncreaseBusiness Wire • 12/12/24
Zoetis Inc. (ZTS) Piper Sandler 36th Annual Healthcare Conference (Transcript)Seeking Alpha • 12/04/24
Zoetis Inc. (ZTS) Management presents at Jefferies London Healthcare Conference (Transcript)Seeking Alpha • 11/20/24
1 Magnificent S&P 500 Dividend Stock Down 12% to Buy After Its Recent PullbackThe Motley Fool • 11/11/24